Radiotherapy & Oncology
Издатель: Elsevier · ISSN 0167-8140 · 66 статей
- Dose-effect analysis of late dental adverse effects following radiation therapy in survivors of paediatric head and neck rhabdomyosarcoma
- Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial
- Enabling gantry-less radiotherapy through upright patient positioning: Current consensus and future direction
- Evaluating imputation methods for longitudinal clinical trajectories: Toxicities in head and neck cancer treatment
- Uncertainty-aware auto-segmentation enables adaptive radiotherapy planning of liver metastases
- Multi-center comparison of relative stopping power estimation of an ex vivo phantom using clinical X-ray CT scanners and a proton CT prototype
- Deep learning-based spot weight generation for online adaptive IMPT: implementation and technical feasibility on a clinical delivery system
- Selective lipid metabolic remodelling in radiosensitive normal tissues after FLASH radiotherapy
- LINACS: a living systematic review of the safety of concurrent stereotactic radiotherapy and novel systemic therapies by the ESTRO/EORTC OligoCare Consortium
- Optimising proton therapy referral pathways for lung and oesophageal cancer in a Dutch interorganisational referral network: A canonical action research study
- The European particle therapy network at 10 years: milestones achieved and the road ahead
- Comment on “Machine learning model for predicting interfraction motion of the seminal vesicles in prostate cancer radiotherapy”
- Response to Comment on “Machine learning model for predicting interfraction motion of the seminal vesicles in prostate cancer radiotherapy”
- Cognitive outcomes of low-dose whole-brain radiation therapy in mild Alzheimer’s disease: A multicenter, randomized, sham-controlled phase II clinical trial
- DAG-informed analysis of muscle characteristics and overall survival in patients receiving radical treatment for bladder cancer
- Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268)
- IAP inhibition enhances response to radiotherapy and chemotherapy in preclinical models of rectal cancer
- Sexual dysfunction in men after radiotherapy for squamous cell carcinoma of the Anus: A danish anal cancer group DACG study
- From contouring variability to dosimetric impact: a comprehensive assessment of online adaptive MR-guided SBRT for pancreatic cancer
- Survival outcomes of treatment strategies for cTanyN3M0 esophageal cancer: A nationwide population-based study
- Sleep-related symptoms are associated with survival in oropharyngeal cancer radiotherapy survivors: Temporal characterization of patient-reported outcomes in a large-scale prospective longitudinal cohort
- Regular post-treatment surveillance is associated with improved survival in nasopharyngeal carcinoma: a retrospective study
- Planned versus accumulated dose in radiotherapy of oropharyngeal carcinoma – Do recurrences occur in unintended cold spots?
- Patient reported swallowing outcomes after prophylactic versus reactive gastrostomy during chemoradiotherapy for head and neck cancer: Results from the SwallPEG randomized trial
- Real-world clinical outcomes of deep learning-based versus manual proton therapy planning for oropharyngeal cancer: A matched cohort study
- A prospective randomized evaluation of AI assisted GTV contouring in head-and-neck radiotherapy
- Patient selection for proton therapy in lung cancer: Updating and internal-external cross-validation of a normal tissue complication probability model for acute oesophageal toxicity
- Particle therapy for T3N0M0 non-small cell lung cancer: a Japanese nationwide prospective registry study
- Repeated metastasis-directed radiotherapy in patients with oligorecurrent prostate cancer: outcomes and risk stratification from a large multinational PSMA PET-guided cohort
- MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study